Skip to content
Review Open access

Ventilator-Associated Pneumonia: The Role of Kidney–Lung Crosstalk and Renal Replacement Therapy, a Narrative Review

Sep 2026 · Journal of Clinical Medicine · Vol 15, pp. 7570 · 0 citations · 108 references
Medicine

TL;DR

Kidney–lung crosstalk is a major driver of organ dysfunction in critical illness, yet translation into targeted therapies remains limited, while future advances will rely on biological phenotyping, biomarker-guided risk stratification, and robust causal inference approaches.

Abstract

Background/Objectives: Multiple organ dysfunction syndrome (MODS) results from dynamic inter-organ interactions rather than isolated organ failures. Among these, kidney–lung crosstalk is a key determinant of outcomes in critically ill patients. Acute kidney injury (AKI) promotes pulmonary dysfunction through hemodynamic, inflammatory, endothelial, and metabolic mechanisms, while acute respiratory failure and mechanical ventilation may aggravate renal injury. Ventilator-associated pneumonia (VAP) may represent a clinical consequence of these interactions, although causality remains uncertain. Renal replacement therapy (RRT) may further influence kidney–lung crosstalk through several physiological mechanisms. To summarize current evidence on kidney–lung crosstalk, evaluate its potential contribution to VAP susceptibility, and examine the role of RRT in modulating these interactions. Methods: Narrative review of experimental, translational, and clinical studies investigating bidirectional kidney–lung interactions in critical illness. Results: Kidney-to-lung crosstalk involves fluid overload, venous congestion, immune activation, endothelial dysfunction, and metabolic disturbances. Lung-to-kidney signaling is driven by mechanical ventilation, ventilator-induced lung injury, hypoxemia, and hypercapnia. Clinical evidence is strongest for fluid overload, venous congestion, and mechanical ventilation, whereas endothelial dysfunction and uremic toxins remain supported mainly by experimental data. AKI-associated immune dysfunction and prolonged mechanical ventilation provide biologically plausible mechanisms linking AKI to VAP, but definitive causal evidence is lacking because of methodological limitations. RRT may influence these interactions through optimized fluid balance, correction of acid–base disorders, improved antimicrobial pharmacokinetics, and potentially extracorporeal immunomodulation. However, no randomized trial has demonstrated a direct reduction in VAP incidence attributable to RRT. Conclusions: Kidney–lung crosstalk is a major driver of organ dysfunction in critical illness, yet translation into targeted therapies remains limited. Current evidence supports integrated organ-protective strategies—including lung-protective ventilation, individualized fluid management, VAP prevention, and optimized antimicrobial therapy—while future advances will rely on biological phenotyping, biomarker-guided risk stratification, and robust causal inference approaches.

Read PDF

Similar papers

Review Open access Oct 2026

Mechanical ventilation–associated AKI: toward a multimodal and kidney-protective ventilatory framework

Mechanical ventilation–associated acute kidney injury (AKI) represents a complex manifestation of lung–kidney cross-talk driven by hemodynamic alterations, neurohumoral activation, systemic inflammation and disturbances in gas exchange and acid–base homeostasis. Beyond static ventilatory settings, increasing evidence s...

Ying Gao, Yi-Peng Fang, S. de Rosa et al. · 0 citations
Review Open access Nov 2026

Renal recovery after sepsis-associated acute kidney injury: multicellular responses and therapeutic implications

Sepsis is life-threatening organ dysfunction caused by a dysregulated host response to infection, and the kidney is a common site of injury. Sepsis-associated acute kidney injury (SA-AKI) has been reported in approximately half of hospitalised patients with sepsis and is associated with increased mortality and subseque...

Meng-Han Zhao, Fei Shao, Xiao Liang et al. · 0 citations
Review Oct 2026

The lung-gut axis and airway inflammation in COPD

Abstract Objective Chronic obstructive pulmonary disease (COPD) is a common lung disease characterized by multiple persistent respiratory symptoms and decreased lung function. Despite extensive research exploring the complex pathogenic mechanisms and signaling pathways underlying COPD, there are currently no effective...

Huang-Zhi-Wei Huang, Shuai Huang, Xun He et al. · 0 citations
Review Open access Oct 2026

COPD: From Endothelium to New Therapies

Chronic Obstructive Pulmonary Disease (COPD) is a heterogeneous, progressive inflammatory condition of the airways and lung parenchyma, representing one of the leading causes of morbidity and mortality worldwide. Traditionally framed as a disease of airflow obstruction, COPD is now increasingly recognized as a systemic...

L. Mondini, Mattia Ramaccia, Michael Hughes et al. · 0 citations
Review Open access Sep 2026

Glutathione Depletion in Acute Respiratory Distress Syndrome: Mechanistic Significance and Potential Association with Ventilatory Support

An overview of the role of glutathione in the pathophysiological sequelae of ARDS is provided, its relevance in COVID-19-related lung injury is highlighted, and its potential as a clinical marker to predict the need for mechanical ventilation is explored.

Brandon T. Tran, Elaine Nguyen, S. Karthikeyan et al. · 0 citations
Review Open access 2026

The Gut-Lung Axis in Chronic Obstructive Pulmonary Disease: Mechanistic Evidence and Traditional Chinese Medicine Interventions

: Chronic obstructive pulmonary disease (COPD) is a heterogeneous lung disorder accompanied by systemic immune, metabolic and mucosal dysfunction. We reviewed clinical and experimental evidence for the gut-lung axis and assessed how traditional Chinese medicine (TCM) interventions map onto defined biological nodes. Hum...

Xin-Yi Zang, Qiang Wang · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.